Trials / Conditions / Thrombotic Microangiopathy

Thrombotic Microangiopathy

12 registered clinical trials studyying Thrombotic Microangiopathy — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopa NCT07347990	First Affiliated Hospital of Zhejiang University	N/A
Recruiting	Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In NCT07059026	ITAC (Instituto de Trasplantes y Alta Complejidad)	—
Active Not Recruiting	N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy NCT07279610	The First Affiliated Hospital of Soochow University	Phase 2 / Phase 3
Unknown	French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy" NCT05991245	University Hospital, Tours	—
Terminated	Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger NCT04743804	Alexion Pharmaceuticals, Inc.	Phase 3
Unknown	Incidence of Snakebite Associated Thrombotic Microangiopathy & Role of Peripheral Blood Smear as a Predictor o NCT04845022	Jubilee Mission Medical College and Research Institute	—
Completed	Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant NCT04543591	Alexion Pharmaceuticals, Inc.	Phase 3
Completed	Study of Ravulizumab in Pediatric Participants With HSCT-TMA NCT04557735	Alexion Pharmaceuticals, Inc.	Phase 3
Completed	Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants NCT02604420	Weill Medical College of Cornell University	—
Terminated	Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy NCT00726544	Archemix Corp.	Phase 2
Terminated	International Registry and Biorepository for TMA(Thrombotic Microangiopathy) NCT00593229	Northwell Health	—
Available	OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy NCT02355782	Michal Nowicki	—